Works matching IS 00333158 AND DT 2023 AND VI 240 AND IP 8
Results: 15
Isoalantolactone relieves depression-like behaviors in mice after chronic social defeat stress via the gut-brain axis.
- Published in:
- Psychopharmacology, 2023, v. 240, n. 8, p. 1775, doi. 10.1007/s00213-023-06413-8
- By:
- Publication type:
- Article
Effects of the dopamine depleting agent tetrabenazine in tests evaluating different components of depressive-like behavior in mice: sex-dependent response to antidepressant drugs with SERT and DAT blocker profiles.
- Published in:
- Psychopharmacology, 2023, v. 240, n. 8, p. 1615, doi. 10.1007/s00213-023-06412-9
- By:
- Publication type:
- Article
Antidepressant effects of novel positive allosteric modulators of Trk-receptor mediated signaling – a potential therapeutic concept?
- Published in:
- Psychopharmacology, 2023, v. 240, n. 8, p. 1789, doi. 10.1007/s00213-023-06410-x
- By:
- Publication type:
- Article
Correction to: Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Effects of the atypical antipsychotic and D3/D2 dopamine partial agonist cariprazine on effort-based choice behavior: implications for modeling avolition.
- Published in:
- Psychopharmacology, 2023, v. 240, n. 8, p. 1747, doi. 10.1007/s00213-023-06405-8
- By:
- Publication type:
- Article
Effects of environmental and pharmacological manipulations on cocaine-vs-negative reinforcer choice in male and female rats.
- Published in:
- Psychopharmacology, 2023, v. 240, n. 8, p. 1677, doi. 10.1007/s00213-023-06404-9
- By:
- Publication type:
- Article
Sestrin-2 and hypoxia-ınducible factor-1 alpha levels in major depressive disorder and its subtypes.
- Published in:
- Psychopharmacology, 2023, v. 240, n. 8, p. 1691, doi. 10.1007/s00213-023-06402-x
- By:
- Publication type:
- Article
Sex differences in neuroendocrine, sympathetic nervous system, and affect responses to acute stress in cannabis users.
- Published in:
- Psychopharmacology, 2023, v. 240, n. 8, p. 1805, doi. 10.1007/s00213-023-06400-z
- By:
- Publication type:
- Article
Clinical outcome data of anxiety patients treated with cannabis-based medicinal products in the United Kingdom: a cohort study from the UK Medical Cannabis Registry.
- Published in:
- Psychopharmacology, 2023, v. 240, n. 8, p. 1735, doi. 10.1007/s00213-023-06399-3
- By:
- Publication type:
- Article
Clozapine but not lithium reverses aberrant tyrosine uptake in patients with bipolar disorder.
- Published in:
- Psychopharmacology, 2023, v. 240, n. 8, p. 1667, doi. 10.1007/s00213-023-06397-5
- By:
- Publication type:
- Article
The effects of hydrocortisone and yohimbine on human behavior in approach-avoidance conflicts.
- Published in:
- Psychopharmacology, 2023, v. 240, n. 8, p. 1705, doi. 10.1007/s00213-023-06396-6
- By:
- Publication type:
- Article
Effect of lithium administration on brain activity under an emotion regulation paradigm in healthy participants: a functional magnetic resonance imaging study.
- Published in:
- Psychopharmacology, 2023, v. 240, n. 8, p. 1719, doi. 10.1007/s00213-023-06395-7
- By:
- Publication type:
- Article
Hippocampal proteins discovery of Panax quinquefolius and Acorus gramineus ameliorating cognitive impairment in diabetic rats.
- Published in:
- Psychopharmacology, 2023, v. 240, n. 8, p. 1759, doi. 10.1007/s00213-023-06393-9
- By:
- Publication type:
- Article
Assessing attention and impulsivity in the variable stimulus duration and variable intertrial interval rodent continuous performance test schedules using dopamine receptor antagonists in female C57BL/6JRj mice.
- Published in:
- Psychopharmacology, 2023, v. 240, n. 8, p. 1651, doi. 10.1007/s00213-023-06387-7
- By:
- Publication type:
- Article
Assessing attention and impulsivity in the variable stimulus duration and variable intertrial interval rodent continuous performance test schedules using noradrenaline receptor antagonists in female C57BL/6JRj mice.
- Published in:
- Psychopharmacology, 2023, v. 240, n. 8, p. 1629, doi. 10.1007/s00213-023-06385-9
- By:
- Publication type:
- Article